Rosetta Genomics Gains CAP Accreditation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics said today that it has received accreditation from the College of American Pathologists' Laboratory Accreditation Program.

The cancer molecular diagnostic testing company has labs in Philadelphia and in Israel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.